Get the tools used by (smart)2 investors.
SP500 0.5%DOW 0.3%FTSE 100 1.5%NIKKEI 0.7%OIL -0.5%GOLD 0.2%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Common Equity for Fuji Pharma Co., Ltd.

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

FUP: Fuji Pharma Co., Ltd.

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, ...

7.90 EUR
Price
– EUR
Fair Value
–
Upside
7.05 - 10.30
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Fuji Pharma Co., Ltd.'s Common Equity:

Sep 2016Sep 2018Sep 2020Sep 2022Sep 2024200 M250 M300 M350 M400 M
Performance Summary
  • Fuji Pharma's common equity last quarter was 293 million
  • Fuji Pharma's common equity for fiscal years ending September 2020 to 2024 averaged 274.9 million.
  • Fuji Pharma's operated at median common equity of 260.6 million from fiscal years ending September 2020 to 2024.
  • Looking back at the last 5 years, Fuji Pharma's common equity peaked in September 2020 at 323 million.
  • Fuji Pharma's common equity hit its 5-year low in September 2022 of 252.4 million.
  • Fuji Pharma's common equity decreased in 2020 (323 million, -3.3%), 2021 (253.5 million, -21.5%), and 2022 (252.4 million, -0.4%) and increased in 2023 (260.6 million, +3.2%) and 2024 (284.7 million, +9.2%).

How does Fuji Pharma's Common Equity benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Fuji Pharma Co., Ltd. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Fuji Pharma Common Equity Benchmarks
NameTickerCommon Equity
HealthcareSECTOR:HLTH.JP71.951 M
Fuji Pharma Co., Ltd.DB:FUP293 M
Nippon Chemiphar Co LtdTSE:453918.474 B
Astena Holdings Co LtdTSE:809525.056 B
Daito Pharmaceutical Co LtdTSE:457751.529 B
JCR Pharmaceuticals Co LtdTSE:455252.571 B
Seikagaku CorpTSE:454873.947 B
Kyorin Holdings IncTSE:4569130.1 B
Kaken Pharmaceutical Co LtdTSE:4521155.3 B
Nippon Shinyaku Co LtdTSE:4516247.5 B
Tsumura & CoTSE:4540291.9 B
Shionogi & Co., Ltd.TSE:45071,345.6 B

Metric Usage: Common Equity

Hide this widget
equity_common
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Common Equity in the financials category include:

  • Tangible Equity - The book value of total equity less intangible assets.
  • Asset Management Fee - This item represents the fees earned from managing the assets of a third party. Also includes fees earned on providing banking services like check writing, credit cards and debit cards, brokerage features like buying securities and making loans on margin & the convenience of having all financial transactions listed on one monthly statement.
  • Deferred Compensation - An amount of stock set aside for purchase through employee compensation deferral plans.
  • Book Value / Share - The book value of common equity on a per basic share basis.
View Full List

Search for metric or datapoint

Common Equity

The sum of all common equity items

Definition of Common Equity

Hide this widget

Fuji Pharma reported common equity of 293 M for the latest quarter ending December 31, 2024 on its balance sheet.

The tables below summarizes Fuji Pharma’s Common Equity and common size over the last five years:

Fiscal YearCommon EquityAssets% Assets
2020-09-30323 M500.9 M64.5%
2021-09-30253.5 M498.4 M50.9%
2022-09-30252.4 M532.6 M47.4%
2023-09-30260.6 M540.1 M48.3%
2024-09-30284.7 M562.4 M50.6%

The tables below summarizes Fuji Pharma’s Common Equity and common size over the last four quarters:

Quarter EndingCommon EquityAssets% Assets
2024-03-31269.8 M520.5 M51.8%
2024-06-30260.9 M513.4 M50.8%
2024-09-30284.7 M562.4 M50.6%
2024-12-31293 M578.3 M50.7%
Click the link below to download a spreadsheet with an example Common Equity calculation for Fuji Pharma Co., Ltd. below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0 K3 B6 B10.791 B2006001,0001,400

The chart above depicts the distribution of common equity for companies operating in the Healthcare sector in the Developed economic region. Over 2,460 companies were considered in this analysis, and 2,369 had meaningful values. The average common equity of companies in the sector is 332.8 M with a standard deviation of 1.036 B.

Fuji Pharma Co., Ltd.'s Common Equity of 293 M ranks in the 81.0% percentile for the sector. The following table provides additional summary stats:

Common Equity In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,467
Included Constituents2,369
Min-86.058 M
Max10.654 B
Median19.143 M
Mean332.8 M
Standard Deviation1.036 B

You can find companies with similar common equity using this stock screener.

All rights reserved. Terms Of Use